(Q68841877)

English

Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action

scientific article published on 01 August 1987

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3503682

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3503682%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

title

Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3503682

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3503682%20AND%20SRC:MED&resulttype=core&format=json

27 September 2019

1 reference

H A Robertson

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3503682

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3503682%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

G S Robertson

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3503682

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3503682%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

publication date

1 August 1987

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3503682

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3503682%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

published in

Clinical Neuropharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3503682

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3503682%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

volume

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3503682

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3503682%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3503682

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3503682%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

page(s)

384-387

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3503682

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3503682%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

Identifiers

DOI

10.1097/00002826-198708000-00010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3503682

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3503682%20AND%20SRC:MED&resulttype=core&format=json

retrieved

27 September 2019

PubMed publication ID

3503682

1 reference

stated in

Europe PubMed Central

PubMed publication ID

3503682

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3503682%20AND%20SRC:MED&resulttype=core&format=json

(Q68841877)

Combined L-dopa and bromocriptine therapy for Parkinson's disease: a proposed mechanism of action

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)